Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Samsung Biologics (207940) – Change of 15% or More in Revenue or Profit/Loss Structure (Large-Scale Company) / 2025-01-22 Disclosures
  • [Disclosure] SK Square (402340) – Report on Reason for Holding General Shareholders’ Meeting on Concentrated Date / 2025-02-25 Semiconductors
  • [Disclosure] Hana Micron (067310) – Decision on Lawsuit / 2025-07-28 Semiconductors
  • [IR] Samsung Electronics (005930) – Q1 2024 Earnings Presentation / 2024-04-30 IR Room
  • [Disclosure] Hana Micron (067310) – Change in Sales or Profit/Loss Structure by 30% or More / 2025-03-11 Disclosures
  • [Disclosure] HPSP (403870) – Decision on Disposal of Treasury Stocks / 2025-05-12 Semiconductors
  • [Disclosure] SK Hynix (000660 / SKHY) – Provisional Financial Results (Fair Disclosure) / 2024-04-25 Semiconductors
  • [Disclosure] ISU PETASYS (007660) – Change in Revenue or Profit/Loss Structure over 30% / 2024-02-15 Semiconductors

Category: Disclosures

[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2025-04-03

Posted on April 3, 2025August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2025-04-03

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion decided to acquire 589,276 treasury common shares worth approximately KRW 100.0B through on-market purchases to stabilize its stock price and enhance shareholder value, with plans to retire all acquired shares after completion. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Read More “[Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2025-04-03” »

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2025-04-03

Posted on April 3, 2025August 10, 2026 By K-STOCK Editor
[Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2025-04-03

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Aerospace has signed a supply contract worth approximately KRW 371.4B with India’s Larsen & Toubro Limited (L&T) to supply components for the 2nd India K9 Self-Propelled Howitzer Export Project. 📊 [Key Disclosure Contents & Major Financial Figures] 1. Contract Details 2. Contract Amount & Proportion…

Read More “[Disclosure] Hanwha Aerospace (012450) – Supply Contract / 2025-04-03” »

Disclosures, Defense

[Disclosure] Celltrion (068270) – Share Retirement Decision / 2025-04-02

Posted on April 2, 2025August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Share Retirement Decision / 2025-04-02

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion decided through a board resolution to retire 268,385 treasury common shares (book value of approximately KRW 45.2B) to stabilize its stock price and enhance shareholder value, with the retirement scheduled for April 18, 2025. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key…

Read More “[Disclosure] Celltrion (068270) – Share Retirement Decision / 2025-04-02” »

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Modification of Listing (Share Retirement) / 2025-04-02

Posted on April 2, 2025August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Modification of Listing (Share Retirement) / 2025-04-02

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced a modification of listing to reduce 1,101,379 common shares following a share retirement, decreasing the total outstanding common shares to 213,006,740 shares, effective April 7, 2025. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Registration of Share Count…

Read More “[Disclosure] Celltrion (068270) – Modification of Listing (Share Retirement) / 2025-04-02” »

Disclosures, Bio & Healthcare

[Disclosure] ISU PETASYS(007660) – Filing of Lawsuit (Voluntary Disclosure) / 2025-04-01

Posted on April 1, 2025August 1, 2026 By K-STOCK Editor
[Disclosure] ISU PETASYS(007660) – Filing of Lawsuit (Voluntary Disclosure) / 2025-04-01

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary JIO Co., Ltd. and an individual plaintiff filed a lawsuit against ISU PETASYS claiming non-existence of deposit return obligations, contract termination, and damages totaling approximately KRW 16.11B. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Legal Proceeding Developments…

Read More “[Disclosure] ISU PETASYS(007660) – Filing of Lawsuit (Voluntary Disclosure) / 2025-04-01” »

Semiconductors, Disclosures

[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-04-01

Posted on April 1, 2025August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-04-01

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing discloses that Hanwha Ocean signed a construction contract for two Very Large Crude Carriers (VLCCs) worth approximately KRW 378.4B with an Oceanian shipowner. 📊 Key Filing Details & Key Figures Summary 1. Key Contract Details 2. Counterparty & Terms 3. Other Key Reference Information…

Read More “[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-04-01” »

Disclosures, Shipbuilding

[Disclosure] Celltrion (068270) – Approval of Part 1 Clinical Trial Application for Phase 3 Trial of CT-P44 (Darzalex Biosimilar) in Europe / 2025-04-01

Posted on April 1, 2025August 6, 2026 By K-STOCK Editor
[Disclosure] Celltrion (068270) – Approval of Part 1 Clinical Trial Application for Phase 3 Trial of CT-P44 (Darzalex Biosimilar) in Europe / 2025-04-01

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion passed the Part 1 review (clinical design evaluation) for its Phase 3 Clinical Trial Application (CTA) for CT-P44, a Darzalex biosimilar candidate, from the European Medicines Agency (EMA). 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Final…

Read More “[Disclosure] Celltrion (068270) – Approval of Part 1 Clinical Trial Application for Phase 3 Trial of CT-P44 (Darzalex Biosimilar) in Europe / 2025-04-01” »

Disclosures, Bio & Healthcare

[Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2025-04-01

Posted on April 1, 2025August 12, 2026 By K-STOCK Editor
[Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2025-04-01

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor recorded total global sales of 365,812 units in March 2025, representing a 2.0% decrease compared to the same period last year. 📊 [Key Disclosure Contents & Major Figures Summary] 1. Monthly Sales Performance for March 2025 (Unit: Vehicles, %) 2. Cumulative Sales Performance for…

Read More “[Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2025-04-01” »

Disclosures, Automotive

[Disclosure] ISU PETASYS(007660) – Results of Annual General Meeting of Shareholders / 2025-03-31

Posted on March 31, 2025August 1, 2026 By K-STOCK Editor
[Disclosure] ISU PETASYS(007660) – Results of Annual General Meeting of Shareholders / 2025-03-31

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ISU PETASYS approved its FY2024 financial statements (consolidated revenue of KRW 836.9B, operating profit of KRW 101.9B), a cash dividend of KRW 150 per common share, and the re-appointment of an independent director at its AGM. 📊 [Key Disclosure Details & Financial Figures] 1. FY2024 Financial…

Read More “[Disclosure] ISU PETASYS(007660) – Results of Annual General Meeting of Shareholders / 2025-03-31” »

Semiconductors, Disclosures

[Disclosure] PSK Holdings (031980) – Results of Annual General Meeting of Shareholders / 2025-03-31

Posted on March 31, 2025August 5, 2026 By K-STOCK Editor
[Disclosure] PSK Holdings (031980) – Results of Annual General Meeting of Shareholders / 2025-03-31

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary PSK Holdings held its Annual General Meeting of Shareholders, approving all submitted agendas including the 35th fiscal year financial statements, a cash dividend of KRW 700 per share (totaling KRW 15.09B), and the re-appointment of Inside Director Jae-gyun Yang, Independent Director Sa-yoon Kang, and Auditor Kwan-hee…

Read More “[Disclosure] PSK Holdings (031980) – Results of Annual General Meeting of Shareholders / 2025-03-31” »

Semiconductors, Disclosures

Posts pagination

Previous 1 … 131 132 133 … 252 Next
  • [Disclosure] Hanwha Aerospace (012450) – Results of Annual General Meeting of Shareholders / 2024-03-26 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | CAPEX Surge · Foreign Inflows · Target Price Upgrade / 2026-07-16 RESEARCH
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Long-Term Agreement · MLCC & FC-BGA Re-rating · Seller’s Market / 2026-01-21 RESEARCH
  • [Disclosure] SK Hynix (000660 / SKHY) – Market Action & Information Notice (Ex-Dividend Reference Price) / 2024-03-27 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Provisional Operating Results (Consolidated) / 2025-10-31 Semiconductors
  • [Disclosure] Celltrion (068270) – Approval of U.S. FDA BLA for Stoboclo & Osenvelt (CT-P41, Prolia & Xgeva Biosimilars) / 2025-03-04 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Investor Relations (IR) Holding / 2025-02-14 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | AI6 Direct Beneficiary · FC-BGA TAM Expansion · MLCC Price Hike / 2026-03-05 RESEARCH

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme